tiprankstipranks
Trending News
More News >
Rapid Dose Therapeutics Corp (TSE:DOSE)
:DOSE
Canadian Market

Rapid Dose Therapeutics Corp (DOSE) Income Statement

Compare
7 Followers

Rapid Dose Therapeutics Corp Income Statement

Last quarter (Q2 2026), Rapid Dose Therapeutics Corp's total revenue was C$672.92K, an increase of 30.43% from the same quarter last year. In Q2, Rapid Dose Therapeutics Corp's net income was C$-825.47K. See Rapid Dose Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 22Dec 20
Total Revenue
C$ 2.09MC$ 1.02MC$ 718.30KC$ 1.75MC$ 755.20K
Gross Profit
C$ 1.18MC$ 563.41KC$ 372.40KC$ 1.34MC$ 699.85K
Operating Expenses
C$ -4.22MC$ 4.30MC$ 4.18MC$ 5.78MC$ 2.33M
Depreciation and Amortization
C$ 240.75KC$ 620.31KC$ 627.44KC$ 765.81KC$ 675.47K
EBITDA
C$ -3.93MC$ -3.02MC$ -2.92MC$ -7.59MC$ -987.00K
Operating Income
C$ 5.40MC$ -3.74MC$ -3.81MC$ -4.43MC$ -1.78M
Other Income/Expenses
C$ -10.81MC$ -568.00KC$ -1.61KC$ -4.05MC$ -28.04K
Pretax Income
C$ -5.40MC$ -4.31MC$ -3.81MC$ -8.49MC$ -1.80M
Net Income
C$ -5.40MC$ -4.31MC$ -3.81MC$ -8.49MC$ -1.80M
Per Share Metrics
Basic EPS
C$ -0.04C$ -0.04C$ -0.04C$ -0.08C$ -0.02
Diluted EPS
C$ -0.04C$ -0.04C$ -0.04C$ -0.08C$ -0.02
Weighted Average Shares Outstanding
124.57M 104.96M 103.42M 100.22M 77.79M
Weighted Average Shares Outstanding (Diluted)
124.57M 104.96M 103.42M 100.22M 77.79M
Currency in CAD

Rapid Dose Therapeutics Corp Earnings and Revenue History